Two Major Scientific Meetings Slated Next Week

Two major scientific meetings will be taking place next week--one marked by controversy, the other by change. Denver is the site of the spring meeting of the American Chemical Society (ACS), set for March 28-April 2. ACS officials say they are unfazed by a boycott of the state of Colorado by gay-rights activists and others angry about the passage in November of Amendment 2, an amendment to the state constitution banning local antidiscrimination laws for homosexuals. At press time, the boycott

Written byBarbara Spector
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Denver is the site of the spring meeting of the American Chemical Society (ACS), set for March 28-April 2. ACS officials say they are unfazed by a boycott of the state of Colorado by gay-rights activists and others angry about the passage in November of Amendment 2, an amendment to the state constitution banning local antidiscrimination laws for homosexuals.

At press time, the boycott had "not materially affected our attendance yet," according to Christine Pruitt of the society's meetings office, although she acknowledges receipt of several letters from people saying they will not be coming to the meeting because of its location. About 10,000 to 12,000 people generally attend ACS's spring and fall meetings, society officials say.

The more than 10,000 expected attendees at the conference March 28 to April 1 will encounter more than 5,000 scientific reports, as well as about 600 exhibits from more than 379 companies. Meeting ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies